International Clinical Trial: Phosphate Binder Selection, Dosing Interval Adherence, and Suboptimal Anemia Control in Maintenance Hemodialysis Patients on Roxadustat During the Volume-Based Procurement Transition Period: A Case-Control Study

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128929) titled 'Phosphate Binder Selection, Dosing Interval Adherence, and Suboptimal Anemia Control in Maintenance Hemodialysis Patients on Roxadustat During the Volume-Based Procurement Transition Period: A Case-Control Study' on July 28.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Mindong Hospital of Ningde City

Condition: Stage 5 chronic kidney disease (on maintenance hemodialysis) with kidney-related anemia

Intervention: Suboptimal Anemia Control Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Suboptimal Anem...